Suma Krishnan Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Suma Krishnan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Suma Krishnan. Suma Krishnan is a Vice President, Product Dev. in NEW RIVER PHARMACEUTICALS INC ($NRPH) and a VP, Product Development in NEW RIVER PHARMACEUTICALS INC ($NRPH) and a SVP--Product Development in INTREXON CORP ($XON) and a Chief Operating Officer in Krystal Biotech, Inc. ($KRYS).
Address: 1861 PRATT DRIVE SUITE 1090 BLACKSBURG 24060 VA
Companies in which Suma Krishnan is an Insider
Krystal Biotech, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Suma Krishnan: Chief Operating Officer
Holdings: 1,864,464 shares
Latest Transaction: Mar 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEW RIVER PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Suma Krishnan: VP, Product Development, Vice President, Product Dev.
Holdings: 0 shares
Latest Transaction: Jan 31 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PRECIGEN, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Suma Krishnan: SVP--Product Development
Holdings: 56,657 shares
Current Value: $1,213,026
Latest Transaction: Feb 01 2016
$XON Market Capitalization: $2.53B
$XON Previous Close: $21.41
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Suma Krishnan
Sentiment: All, KRYS, NRPH, XON
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Option Exercise | A | 78.89 | 42,600 | 3,360,714 | 42,600 | |
| Mar 02 2021 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Grant | A | 0.00 | 28,400 | 0 | 1,864,464 | 1.8 M to 1.9 M (+1.55 %) |
| Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 47.29 | 1,126 | 53,248 | 1,836,064 | 1.8 M to 1.8 M (-0.06 %) |
| Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.63 | 7,437 | 346,813 | 1,837,190 | 1.8 M to 1.8 M (-0.40 %) |
| Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.09 | 10,594 | 488,297 | 1,844,627 | 1.9 M to 1.8 M (-0.57 %) |
| Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.85 | 5,142 | 240,896 | 1,855,221 | 1.9 M to 1.9 M (-0.28 %) |
| Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.24 | 9,749 | 450,821 | 1,860,363 | 1.9 M to 1.9 M (-0.52 %) |